AW Tolcher, P LoRusso, J Arzt, TA Busman… - Cancer chemotherapy …, 2015 - Springer
Abstract Purpose Navitoclax (ABT-263), a novel, oral Bcl-2 inhibitor, enhances the antitumor
effects of chemotherapy in vitro by lowering the apoptotic threshold. This phase I study …